IMTIAZ-UMER, S., TAGGAR, J. and ALLSOPP, G., 2021. Education for Primary Care. Published Online First: 10 April 2021, 1-3
TAGGAR, J., SAHA, R., HOPWOOD-CARR, P., PATEL, B. and JOHNSON, C., 2021. Education for Primary Care. Published Online First: 10 April 2021, 1-8
PATEL, B. and TAGGAR, J.S., 2021. Education for Primary Care. Online ahead of print: 28 June 2021, 1-7
ALLSOPP, G., ROSENTHAL, J., BLYTHE, J. and TAGGAR, J.S., 2020. Education for Primary Care. 31(4), 205-209
SAHOTA, G.S. and TAGGAR, J.S., 2020. Medical Teacher. Published Online First: 13 June 2020,
IYEN, B., VAZ, L.R., TAGGAR, J., COOPER, S., LEWIS, S. and COLEMAN, T., 2019. BMJ Open. 9, e024923
TAGGAR, J., QURESHI, N. and WENG, S., 2019. European Journal of Preventive Cardiology. Article first published online: October 4, 2019,
VAN DER WARDT, V., BURTON, J.K., CONROY, S., WELSH, T., LOGAN, P., TAGGAR, J., TANAJEWSKI, L. and GLADMAN, J., 2018. Pilot and Feasibility Studies. 4, 29
VAN OPPEN, J., CAMM, C., SAHOTA, G., TAGGAR, J. and KNOX, R., 2018. Education for Primary Care. Published Online: 26 July 2018, 1-2
ALLSOPP, G. and TAGGAR, J., 2018. Education for Primary Care. 29(5), 301-306
TAGGAR, J.S., COLEMAN, T., LEWIS, S. and JONES, M., 2016. PLoS ONE. 11(4), e0152086
TAGGAR, J.S. and COLEMAN, T., 2016. European Journal of Preventive Cardiology. Published online before print: 2 June 2016, doi: 10.1177/2047487316652976
MACKENZIE, I.S., FORD, I., WALKER, A., HAWKEY, C., BEGG, A., AVERY, A., TAGGAR, J., WEI, L., STRUTHERS, A.D., MACDONALD, T.M. and ON BEHALF OF THE ALL-HEART STUDY GROUP, 2016. BMJ Open. 6(9), e013774
SAHOTA, G. and TAGGAR, J.S., 2016. British Journal of General Practice. 66(649), 406-406
TAGGAR, J. S., COLEMAN, T., LEWIS, S., HENEGHAN, C. and JONES, M., 2015. International Journal of Cardiology. 184, 175-183
TAGGAR, J., LEWIS, S., DOCHERTY, G., BAULD, L., MCEWEN, A. and COLEMAN, T., 2015. Substance Abuse Treatment, Prevention, and Policy. 10(1), 15
TAGGAR, J.S., COLEMAN, T., LEWIS, S., HENEGHAN, C. and JONES, M., 2015. European Journal of Preventive Cardiology. First Published Online: 13 October 2015, doi: 10.1177/2047487315611347
HARRISON, J.K., VAN DER WARDT, V., GLADMAN, J., TAGGAR, J. and CONROY, S., 2015. Journal of Human Hypertension. 29(10), 630
KWOK, T.C., TAGGAR, J., COOPER, S., LEWIS, S. and COLEMAN, T., 2014. Nicotine and Tobacco Research. 16(2), 145-154
COOPER, S., TAGGAR, J., LEWIS, S., MARLOW, N., DICKINSON, A., WHITEMORE, R. and COLEMAN, T., 2014. The Lancet Respiratory Medicine. Early Online Publication: 11 August 2014, doi:10.1016/S2213-2600(14)70157-2
COOPER, S., LEWIS, S., THORNTON, J.G., MARLOW, N., WATTS, K., BRITTON, J., GRAINGE, M.J., TAGGAR, J., ESSEX, H., PARROTT, S., DICKINSON, A., WHITEMORE, R., COLEMAN, T. and FOR THE SMOKING, NICOTINE AND PREGNANCY (SNAP) TRIAL TEAM,, 2014. Health Technology Assessment. 18(54), doi:10.3310/hta18540
COOPER, S., TAGGAR, J., LEWIS, S., MARLOW, N., DICKINSON, A., WHITEMORE, R. and COLEMAN, T., 2013. The Lancet. 382, S7
TAGGAR, J., COLEMAN, T., LEWIS, S. and SZATKOWSKI, L., 2012. BMC Public Health. 12(1), 329
BHALA, N., TAGGAR, J.S., RAJASEKHAR, P. and BANERJEE, A., 2011. British Medical Journal. 343, d4264
TAGGAR, J.S. and HODSON, A., 2011. The assessment and management of palpitations in primary care. InnovAiT. 4, 408-413
FITZMAURICE, D.A., TAGGAR, J.S. and JOHNS, S.J., 2010. Atrial Fibrillation and Antithrombotic Therapy. RCGP News. 5, 6
JOHNS, S.J. and TAGGAR, J.S., 2010. Atrial Fibrillation. InnovAiT. 3, 578-586
TAGGAR, J.S., 2010. Audit of atrial fibrillation management at a district general hospital. British Journal of Cardiology. 17, 122
TAGGAR, J.S., 2009. Chapter 15: Angiotensin II receptor blockers and hypertension. In: LIP, G. and NADAR, S., eds., Hypertension Oxford University Press.
TAGGAR, J.S., WATSON, T., MUSARRAT, K. and MILLANE, T., 2009. International Journal of Cardiology. 136(2), e29-e30
TAGGAR, J.S. and LIP, G.Y.H., 2008. Idraparinux for the prevention of thromboembolism in patients with atrial fibrillation. Therapy Weekly. 5, 139-140
TAGGAR, J.S. and LIP, G.Y. H., 2008. Current Medical Research and Opinion. 24(5), 1455-1458
TAGGAR, J.S. and LIP, G.Y.H., 2008. Europace. 10(1), 6-8
TAGGAR, J.S. and LIP, G.Y.H., 2008. The QRISK was less likely to overestimate cardiovascular risk than the Framingham or ASSIGN equations. American College of Physicians Journal Club. 148, 25
TAGGAR, J.S. and LIP, G.Y.H., 2008. Europace. 10(1), 1-2
TAGGAR, J.S., MARIN, F. and LIP, G.Y.H., 2008. Mortality in patients with atrial fibrillation: improving or not? Europace. 10, 389-390
TAGGAR, J.S., WATSON, T. and LIP, G.Y.H., 2008. Stroke. 39(2), e24-e25
TAGGAR, J.S. and CAREY, P.A., 2007. Adenosine challenge in the diagnosis of in-apparent accessory pathways. New Zealand Medical Journal. 120(1267), U2873
TAGGAR, J.S. and LIP, G.Y.H., 2007. Identifying atrial fibrillation in primary care. Mims Cardiovascular. 2, 18-20
BHALA, N. and TAGGAR, J., 2006. The Lancet. 367(9513), 812-813
TAGGAR, J.S. and LIP, G.Y.H., Atrial fibrillation: Current approaches to drug therapy. Prescriber. 19, 48-59